Bintrafusp Alfa in the Second-Line Treatment of Patients With NSCLC

J Thorac Oncol. 2021 Apr;16(4):e23-e24. doi: 10.1016/j.jtho.2020.04.037.

Authors

Jiasheng Xu¹, Han Nie¹, Hongping Wan²

Affiliations

¹ Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Jiangxi, People's Republic of China.
² Department of Pathology, The First Affiliated Hospital of Nanchang University, Jiangxi, People's Republic of China. Electronic address: icqyq86@163.com.

PMID: 33781446
DOI: 10.1016/j.jtho.2020.04.037

No abstract available

Publication types

Letter
Comment

MeSH terms

B7-H1 Antigen
Carcinoma, Non-Small-Cell Lung* / drug therapy
Humans
Immunologic Factors
Lung Neoplasms* / drug therapy
Transforming Growth Factor beta

Substances

B7-H1 Antigen
Immunologic Factors
Transforming Growth Factor beta